Literature DB >> 1518840

Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells.

D A McClain1, A J Paterson, M D Roos, X Wei, J E Kudlow.   

Abstract

We have investigated the regulation of the expression of two growth factors found in vascular smooth muscle, transforming growth factor alpha (TGF alpha) and basic fibroblast growth factor (bFGF). Cells cultured in medium containing 30 mM glucose exhibited a 2-fold increase in TGF alpha mRNA and a 3-fold increase in bFGF mRNA compared with cells grown in normal (5.5 mM) glucose. Glucosamine was more potent than glucose, leading to a 6-fold increase in TGF alpha mRNA. TGF alpha protein levels were also increased by glucosamine treatment, and the predominant species present was the membrane-bound precursor form of TGF alpha. To examine further the regulation of growth factors by sugars, cultured rat aortic smooth muscle cells were transfected with a plasmid construct consisting of a 1.2-kilobase-pair fragment of the TGF alpha promoter linked to a luciferase reporter gene. Increasing the concentration of glucose in the culture medium from 5.5 mM to 30 mM led to a rapid, 1.7-fold increase in the activity of the TGF alpha promoter. Glucosamine was much more potent than glucose in this stimulation, with 2 mM glucosamine causing a 12-fold increase in TGF alpha promoter activity. Insulin had no effect on luciferase activity in either the presence or the absence of added sugars. The glucose response element of the TGF alpha gene maps to a 130-base-pair segment that includes three potential binding sites for the transcription factor Sp1. We conclude that high glucose concentrations such as are reached in diabetes mellitus can stimulate the transcription of the genes for growth factors in vascular smooth muscle cells. This signaling pathway apparently involves the metabolism of glucose to glucosamine. This effect could be representative of nutritional regulation of a family of genes and could contribute to the toxicity of hyperglycemia and the vascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518840      PMCID: PMC49874          DOI: 10.1073/pnas.89.17.8150

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins.

Authors:  K P Kearse; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases.

Authors:  S G Mueller; A J Paterson; J E Kudlow
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance.

Authors:  S Marshall; V Bacote; R R Traxinger
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

4.  Insulin regulation of IGF-I expression in rat aorta.

Authors:  L J Murphy; A Ghahary; S Chakrabarti
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

5.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis.

Authors:  R Ross; J Masuda; E W Raines; A M Gown; S Katsuda; M Sasahara; L T Malden; H Masuko; H Sato
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

6.  Transcriptional regulation of the human transforming growth factor-alpha gene.

Authors:  R H Raja; A J Paterson; T H Shin; J E Kudlow
Journal:  Mol Endocrinol       Date:  1991-04

7.  De novo synthesis of diacylglycerol from glucose. A new pathway of signal transduction in human neutrophils stimulated during phagocytosis of beta-glucan particles.

Authors:  F Rossi; M Grzeskowiak; V Della Bianca; A Sbarbati
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

8.  Role of basic fibroblast growth factor in vascular lesion formation.

Authors:  V Lindner; D A Lappi; A Baird; R A Majack; M A Reidy
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

9.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

10.  Cloning of the glutamine:fructose-6-phosphate amidotransferase gene from yeast. Pheromonal regulation of its transcription.

Authors:  G Watzele; W Tanner
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

View more
  35 in total

Review 1.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.

Authors:  S Gadau; C Emanueli; S Van Linthout; G Graiani; M Todaro; M Meloni; I Campesi; G Invernici; F Spillmann; K Ward; P Madeddu
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

3.  A novel glucosamine derivative with low cytotoxicity enhances chondrogenic differentiation of ATDC5.

Authors:  Hang Yao; Jingchen Xue; Renjian Xie; Sa Liu; Yingjun Wang; Wenjing Song; Dong-An Wang; Li Ren
Journal:  J Mater Sci Mater Med       Date:  2017-09-27       Impact factor: 3.896

Review 4.  Role of glucose regulatory mechanisms in diabetic retinopathy.

Authors:  R M Knott; J V Forrester
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

5.  Elevated expression of basic fibroblast growth factor in an immortalized rabbit smooth muscle cell line.

Authors:  J A Winkles; R Friesel; G F Alberts; M F Janat; G Liau
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.

Authors:  X Yang; K Su; M D Roos; Q Chang; A J Paterson; J E Kudlow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

7.  Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneously diabetic BB Wistar rats.

Authors:  P D Winocour; M Richardson; R L Kinlough-Rathbone
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

8.  Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.

Authors:  Satinder Singh; Ehrin J Armstrong; Walid Sherif; Bejan Alvandi; Gregory G Westin; Gagan D Singh; Ezra A Amsterdam; John R Laird
Journal:  Vasc Med       Date:  2014-06-17       Impact factor: 3.239

9.  O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.

Authors:  Udayakumar Karunakaran; Nam Ho Jeoung
Journal:  Korean Diabetes J       Date:  2010-08-31

10.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.

Authors:  Donald A McClain; William A Lubas; Robert C Cooksey; Mark Hazel; Glendon J Parker; Dona C Love; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.